Irene González-Domínguez

14PUBLICATIONS
45CO-AUTHORS
Agricultural molecular engineering of nucleic acids and proteinsNanomaterialsEmergency medicineMedical devicesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 26, 2026
AddaVax, AddaS03, and Alum Effectively Enhance Cross-Reactive and Cross-Neutralizing Antibody Responses Against SARS-CoV-2 Induced by the Inactivated NDV-HXP-S Vaccine in Mice.

José Luis Martínez-Guevara, Tsoi Ying Lai, Mitali Mishra

|Nov 25, 2025
Development of an RT-qPCR and a Next-Generation Sequencing approach to assess viral shedding of NDV-based SARS-CoV-2 variant vaccines.

Marta Boza, Adam Abdeljawad, Stefan Slamanig

|Jan 03, 2025
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.

Victoria Dolange, Stefan Slamanig, Adam Abdeljawad

|Nov 17, 2024
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach.

Irene González-Domínguez, Eduard Puente-Massaguer, Adam Abdeljawad

|Sep 13, 2023
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice.

Eduard Puente-Massaguer, Kirill Vasilev, Annika Beyer

|Feb 15, 2023
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.

Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh

Pageof 3

Frequent Collaborators

8 joint publications

Weina Sun

7 joint publications

Florian Krammer

6 joint publications

Stefan Slamanig

6 joint publications

Peter Palese